{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T06:25:23Z","timestamp":1775111123516,"version":"3.50.1"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s11033-021-07020-6","type":"journal-article","created":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:03:39Z","timestamp":1641427419000},"page":"2465-2474","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Neutralizing antibody: a savior in the Covid-19 disease"],"prefix":"10.1007","volume":"49","author":[{"given":"Sneh Lata","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2180-318X","authenticated-orcid":false,"given":"Rishi Kumar","family":"Jaiswal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"issue":"4","key":"7020_CR1","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1056\/NEJMc2100362","volume":"92","author":"H Lu","year":"2020","unstructured":"Lu H, Stratton CW, Tang YW (2020) Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol 92(4):401\u2013402. https:\/\/doi.org\/10.1056\/NEJMc2100362","journal-title":"J Med Virol"},{"issue":"10223","key":"7020_CR2","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The Lancet 395(10223):507\u2013513. https:\/\/doi.org\/10.1016\/S0140-6736(20)30211-7","journal-title":"The Lancet"},{"issue":"8","key":"7020_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ (2016) SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol 14(8):523\u2013534. https:\/\/doi.org\/10.1038\/nrmicro.2016.81","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"7020_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105948","volume":"55","author":"L Wang","year":"2020","unstructured":"Wang L, Wang Y, Ye D, Liu Q (2020) Review of the 2019 novel coronavirus (SARS-CoV-2) based on current evidence. Int J Antimicrob Agents 55(6):105948. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105948","journal-title":"Int J Antimicrob Agents"},{"issue":"5643","key":"7020_CR5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1126\/science.1087139","volume":"302","author":"Y Guan","year":"2003","unstructured":"Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW et al (2003) Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science 302(5643):276\u2013278. https:\/\/doi.org\/10.1126\/science.1087139","journal-title":"Science"},{"issue":"7798","key":"7020_CR6","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, Yang X-L, Wang X-G, Ben Hu, Zhang L, Zhang W, Si H-R et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579(7798):270\u2013273. https:\/\/doi.org\/10.1038\/s41586-020-2012-7","journal-title":"Nature"},{"issue":"7","key":"7020_CR7","doi-asserted-by":"publisher","first-page":"e00127","DOI":"10.1128\/jvi.00127-20","volume":"94","author":"Y Wan","year":"2020","unstructured":"Wan Y, Shang J, Graham R, Baric RS, Li F (2020) Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus. J Virol 94(7):e00127-e120. https:\/\/doi.org\/10.1128\/jvi.00127-20","journal-title":"J Virol"},{"issue":"9","key":"7020_CR8","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1002\/jmv.25980","volume":"92","author":"A Brufsky","year":"2020","unstructured":"Brufsky A, Lotze MT (2020) DC\/L-SIGNs of hope in the COVID-19 pandemic. J Med Virol 92(9):1396\u20131398. https:\/\/doi.org\/10.1002\/jmv.25980","journal-title":"J Med Virol"},{"key":"7020_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2020.104742","volume":"176","author":"B Coutard","year":"2020","unstructured":"Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E (2020) The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 176:104742. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104742","journal-title":"Antiviral Res"},{"issue":"8","key":"7020_CR10","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.tim.2015.06.003","volume":"23","author":"G Lu","year":"2015","unstructured":"Lu G, Wang Q, Gao GF (2015) Bat-to-human: spike features determining \u201chost jump\u201d of coronaviruses SARS-CoV, MERS-CoV, and beyond. Trends Microbiol 23(8):468\u2013478. https:\/\/doi.org\/10.1016\/j.tim.2015.06.003","journal-title":"Trends Microbiol"},{"issue":"42","key":"7020_CR11","doi-asserted-by":"publisher","first-page":"15214","DOI":"10.1073\/pnas.1407087111","volume":"111","author":"JK Millet","year":"2014","unstructured":"Millet JK, Whittaker GR (2014) Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein. Proc Natl Acad Sci 111(42):15214\u201315219. https:\/\/doi.org\/10.1073\/pnas.1407087111","journal-title":"Proc Natl Acad Sci"},{"issue":"10224","key":"7020_CR12","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","volume":"395","author":"Roujian Lu","year":"2020","unstructured":"Lu Roujian, Zhao Xiang, Li Juan, Niu Peihua, Yang Bo, Honglong Wu, Wang Wenling et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u201374. https:\/\/doi.org\/10.1016\/S0140-6736(20)30251-8","journal-title":"Lancet"},{"issue":"10224","key":"7020_CR13","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/nature02145","volume":"395","author":"W Li","year":"2020","unstructured":"Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, Somasundaran M et al (2020) Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 395(10224):565\u2013574. https:\/\/doi.org\/10.1038\/nature02145","journal-title":"Lancet"},{"issue":"6483","key":"7020_CR14","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1126\/science.abb2507","volume":"367","author":"D Wrapp","year":"2020","unstructured":"Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, Graham BS, McLellan JS (2020) Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science 367(6483):1260\u20131263. https:\/\/doi.org\/10.1126\/science.abb2507","journal-title":"Science"},{"issue":"10223","key":"7020_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Yi Hu, Zhang Li et al (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506. https:\/\/doi.org\/10.1016\/S0140-6736(20)30183-5","journal-title":"Lancet"},{"issue":"2","key":"7020_CR16","doi-asserted-by":"publisher","first-page":"65","DOI":"10.15171\/ijoem.2020.1921","volume":"11","author":"P Habibzadeh","year":"2020","unstructured":"Habibzadeh P, Stoneman EK (2020) The novel coronavirus: A bird\u2019s eye view. Int J Occup Environ Med 11(2):65\u201371. https:\/\/doi.org\/10.15171\/ijoem.2020.1921","journal-title":"Int J Occup Environ Med"},{"issue":"2","key":"7020_CR17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S, Schiergens TS et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280 e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"key":"7020_CR18","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00542-x","author":"PC Taylor","year":"2021","unstructured":"Taylor PC, Adams AC, Hufford MM, de la Torre I, Winthrop K, Gottlieb RL (2021) Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. https:\/\/doi.org\/10.1038\/s41577-021-00542-x","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"7020_CR19","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.bj.2020.11.011","volume":"44","author":"JP Jaworski","year":"2021","unstructured":"Jaworski JP (2021) Neutralizing monoclonal antibodies for COVID-19 treatment and prevention. Biomed J 44(1):7\u201317. https:\/\/doi.org\/10.1016\/j.bj.2020.11.011","journal-title":"Biomed J"},{"issue":"11","key":"7020_CR20","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1038\/s41587-020-0732-8","volume":"38","author":"L DeFrancesco","year":"2020","unstructured":"DeFrancesco L (2020) COVID-19 antibodies on trial. Nat Biotechnol 38(11):1242\u20131252. https:\/\/doi.org\/10.1038\/s41587-020-0732-8","journal-title":"Nat Biotechnol"},{"issue":"11","key":"7020_CR21","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.it.2020.09.004","volume":"41","author":"E Gavor","year":"2020","unstructured":"Gavor E, Choong YK, Er SY, Sivaraman H, Sivaraman J (2020) Structural Basis of SARS-CoV-2 and SARS-CoV Antibody Interactions. Trends Immunol 41(11):1006\u20131022. https:\/\/doi.org\/10.1016\/j.it.2020.09.004","journal-title":"Trends Immunol"},{"issue":"6506","key":"7020_CR22","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1126\/science.abd0827","volume":"369","author":"J Hansen","year":"2020","unstructured":"Hansen J, Baum A, Pascal KE, Russo V, Giordano S, Wloga E, Fulton BO et al (2020) Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science 369(6506):1010\u20131014. https:\/\/doi.org\/10.1126\/science.abd0827","journal-title":"Science"},{"issue":"3","key":"7020_CR23","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1056\/NEJMoa2029849","volume":"384","author":"P Chen","year":"2020","unstructured":"Chen P, Nirula A, Heller B, Gottlieb RL, Boscia J, Morris J et al (2020) SARS-CoV-2 neutralizing antibody LY-CoV555 in outpatients with Covid-19. N Engl J Med 384(3):229\u2013237. https:\/\/doi.org\/10.1056\/NEJMoa2029849","journal-title":"N Engl J Med"},{"issue":"7819","key":"7020_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1038\/s41586-020-2381-y","volume":"584","author":"R Shi","year":"2020","unstructured":"Shi R, Shan C, Duan X, Chen Z, Liu P, Song J et al (2020) A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature 584(7819):120\u2013124. https:\/\/doi.org\/10.1038\/s41586-020-2381-y","journal-title":"Nature"},{"issue":"1","key":"7020_CR25","doi-asserted-by":"publisher","first-page":"5558","DOI":"10.1038\/s41598-021-84840-3","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Zhao J, Nguyen LNT, Adkins JL, Schank M, Khanal S et al (2021) Blockade of SARS-CoV-2 spike protein-mediated cell\u2013cell fusion using COVID-19 convalescent plasma. Sci Rep 11(1):5558. https:\/\/doi.org\/10.1038\/s41598-021-84840-3","journal-title":"Sci Rep"},{"key":"7020_CR26","doi-asserted-by":"publisher","unstructured":"Ehling, R. A., Weber, C. R., Mason, D. M., Friedensohn, S., Wagner, B., Bieberich, F., et al. (2021). Single-cell sequencing of plasma cells from COVID-19 patients reveals highly expanded clonal lineages produce specific and neutralizing antibodies to SARS-CoV-2. bioRxiv,. Doi:https:\/\/doi.org\/10.1101\/2021.02.12.430940.","DOI":"10.1101\/2021.02.12.430940"},{"issue":"3","key":"7020_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100040","volume":"1","author":"MS Suthar","year":"2020","unstructured":"Suthar MS, Zimmerman MG, Kauffman RC, Mantus G, Linderman SL, Hudson WH et al (2020) Rapid generation of neutralizing antibody responses in COVID-19 patients. Cell Rep Med 1(3):100040. https:\/\/doi.org\/10.1016\/j.xcrm.2020.100040","journal-title":"Cell Rep Med"},{"issue":"1","key":"7020_CR28","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/s41467-021-21111-9","volume":"12","author":"S Marot","year":"2021","unstructured":"Marot S, Malet I, Leducq V, Zafilaza K, Sterlin D, Planas D et al (2021) Rapid decline of neutralizing antibodies against SARS-CoV-2 among infected healthcare workers. Nat Commun 12(1):844. https:\/\/doi.org\/10.1038\/s41467-021-21111-9","journal-title":"Nat Commun"},{"key":"7020_CR29","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abd2223","author":"D Sterlin","year":"2021","unstructured":"Sterlin D, Mathian A, Miyara M, Mohr A, Anna F, Cla\u00ebr L et al (2021) IgA dominates the early neutralizing antibody response to SARS-CoV-2. Sci Transl Med. https:\/\/doi.org\/10.1126\/scitranslmed.abd2223","journal-title":"Sci Transl Med"},{"issue":"6521","key":"7020_CR30","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1126\/science.abd7728","volume":"370","author":"A Wajnberg","year":"2020","unstructured":"Wajnberg A, Amanat F, Firpo A, Altman DR, Bailey MJ et al (2020) Robust neutralizing antibodies to SARS-CoV-2 infection persist for months. Science 370(6521):1227\u20131230. https:\/\/doi.org\/10.1126\/science.abd7728","journal-title":"Science"},{"issue":"6","key":"7020_CR31","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long QX, Liu BZ, Deng HJ, Wu GC, Deng K, Chen YK et al (2020) Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med 26(6):845\u2013848. https:\/\/doi.org\/10.1038\/s41591-020-0897-1","journal-title":"Nat Med"},{"issue":"9","key":"7020_CR32","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1002\/jmv.25961","volume":"92","author":"K Rajendran","year":"2020","unstructured":"Rajendran K, Krishnasamy N, Rangarajan J, Rathinam J, Natarajan M, Ramachandran A (2020) Convalescent plasma transfusion for the treatment of COVID-19: Systematic review. J Med Virol 92(9):1475\u20131483. https:\/\/doi.org\/10.1002\/jmv.25961","journal-title":"J Med Virol"},{"issue":"5","key":"7020_CR33","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/j.mayocp.2021.02.008","volume":"96","author":"SA Klassen","year":"2021","unstructured":"Klassen SA, Senefeld JW, Johnson PW, Carter RE, Wiggins CC, Shoham S et al (2021) The effect of convalescent plasma therapy on mortality among patients with COVID-19: systematic review and meta-analysis. Mayo Clin Proc 96(5):1262\u20131275. https:\/\/doi.org\/10.1016\/j.mayocp.2021.02.008","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"7020_CR34","doi-asserted-by":"publisher","first-page":"5563","DOI":"10.1038\/s41598-021-84733-5","volume":"11","author":"K Maeda","year":"2021","unstructured":"Maeda K, Higashi-Kuwata N, Kinoshita N, Kutsuna S, Tsuchiya K, Hattori S-I et al (2021) Neutralization of SARS-CoV-2 with IgG from COVID-19-convalescent plasma. Sci Rep 11(1):5563. https:\/\/doi.org\/10.1038\/s41598-021-84733-5","journal-title":"Sci Rep"},{"issue":"2","key":"7020_CR35","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271-280 e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052","journal-title":"Cell"},{"issue":"11","key":"7020_CR36","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.4049\/jimmunol.2001420","volume":"206","author":"G Mantus","year":"2021","unstructured":"Mantus G, Nyhoff LE, Kauffman RC, Edara VV, Lai L, Floyd K et al (2021) Evaluation of cellular and serological responses to acute SARS-CoV-2 infection demonstrates the functional importance of the receptor-binding domain. J Immunol 206(11):2605\u20132613. https:\/\/doi.org\/10.4049\/jimmunol.2001420","journal-title":"J Immunol"},{"issue":"1","key":"7020_CR37","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cell.2020.08.025","volume":"183","author":"N Kaneko","year":"2020","unstructured":"Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, Piechocka-Trocha A et al (2020) Loss of Bcl-6-expressing T Follicular helper cells and germinal centers in COVID-19. Cell 183(1):143-157 e113. https:\/\/doi.org\/10.1016\/j.cell.2020.08.025","journal-title":"Cell"},{"issue":"1","key":"7020_CR38","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.cell.2020.09.013","volume":"183","author":"PF Canete","year":"2020","unstructured":"Canete PF, Vinuesa CG (2020) COVID-19 makes B cells forget, but T cells remember. Cell 183(1):13\u201315. https:\/\/doi.org\/10.1016\/j.cell.2020.09.013","journal-title":"Cell"},{"issue":"12","key":"7020_CR39","doi-asserted-by":"publisher","first-page":"1506","DOI":"10.1038\/s41590-020-00814-z","volume":"21","author":"MC Woodruff","year":"2020","unstructured":"Woodruff MC, Ramonell RP, Nguyen DC, Cashman KS, Saini AS, Haddad NS, Ley AM et al (2020) Extrafollicular B cell responses correlate with neutralizing antibodies and morbidity in COVID-19. Nat Immunol 21(12):1506\u20131516. https:\/\/doi.org\/10.1038\/s41590-020-00814-z","journal-title":"Nat Immunol"},{"issue":"6505","key":"7020_CR40","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1126\/science.abc5343","volume":"369","author":"W Deng","year":"2020","unstructured":"Deng W, Bao L, Liu J, Xiao C, Liu J, Xue J, Lv Q et al (2020) Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques. Science 369(6505):818\u2013823. https:\/\/doi.org\/10.1126\/science.abc5343","journal-title":"Science"},{"key":"7020_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00158-2","author":"Andrew G Letizia","year":"2021","unstructured":"Letizia Andrew G, Ge Yongchao, Vangeti Sindhu, Goforth Carl, Weir Dawn L, Kuzmina Natalia A, Balinsky Corey A et al (2021) SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(21)00158-2","journal-title":"Lancet Respir Med"},{"key":"7020_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abf4063","author":"Jennifer M Dan","year":"2021","unstructured":"Dan Jennifer M, Jose Mateus Yu, Kato Kathryn M, Hastie Esther Dawen, Yu Caterina E, Faliti Alba Grifoni et al (2021) Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. https:\/\/doi.org\/10.1126\/science.abf4063","journal-title":"Science"},{"issue":"7851","key":"7020_CR43","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-021-03207-w","volume":"591","author":"C Gaebler","year":"2021","unstructured":"Gaebler C, Wang Z, Lorenzi JCC, Muecksch F, Finkin S, Tokuyama M, Cho A et al (2021) Evolution of antibody immunity to SARS-CoV-2. Nature 591(7851):639\u2013644. https:\/\/doi.org\/10.1038\/s41586-021-03207-w","journal-title":"Nature"},{"key":"7020_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03647-4","author":"JS Turner","year":"2021","unstructured":"Turner JS, Kim W, Kalaidina E, Goss CW, Rauseo AM, Schmitz AJ, Hansen L et al (2021) SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans. Nature. https:\/\/doi.org\/10.1038\/s41586-021-03647-4","journal-title":"Nature"},{"issue":"3","key":"7020_CR45","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.tim.2020.11.002","volume":"29","author":"R West","year":"2021","unstructured":"West R, Kobokovich A, Connell N, Gronvall GK (2021) COVID-19 antibody tests: a valuable public health tool with limited relevance to individuals. Trends Microbiol 29(3):214\u2013223. https:\/\/doi.org\/10.1016\/j.tim.2020.11.002","journal-title":"Trends Microbiol"},{"issue":"9","key":"7020_CR46","doi-asserted-by":"publisher","first-page":"e245","DOI":"10.1016\/S1473-3099(20)30517-X","volume":"20","author":"RW Peeling","year":"2020","unstructured":"Peeling RW, Wedderburn CJ, Garcia PJ, Boeras D, Fongwen N, Nkengasong J et al (2020) Serology testing in the COVID-19 pandemic response. Lancet Infect Dis 20(9):e245\u2013e249. https:\/\/doi.org\/10.1016\/S1473-3099(20)30517-X","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"7020_CR47","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/s41467-020-20247-4","volume":"12","author":"EHY Lau","year":"2021","unstructured":"Lau EHY, Tsang OTY, Hui DSC, Kwan MYW, Chan W-H, Chiu SS, Ko RLW et al (2021) Neutralizing antibody titres in SARS-CoV-2 infections. Nat Commun 12(1):63. https:\/\/doi.org\/10.1038\/s41467-020-20247-4","journal-title":"Nat Commun"},{"issue":"1","key":"7020_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/cpim.116","volume":"131","author":"A Vanderheiden","year":"2020","unstructured":"Vanderheiden A, Edara VV, Floyd K, Kauffman RC, Mantus G, Anderson E, Rouphael N et al (2020) Development of a rapid focus reduction neutralization test assay for measuring SARS-CoV-2 neutralizing antibodies. Curr Protoc Immunol 131(1):e116. https:\/\/doi.org\/10.1002\/cpim.116","journal-title":"Curr Protoc Immunol"},{"key":"7020_CR49","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201181","author":"Fabian Schmidt","year":"2020","unstructured":"Schmidt Fabian, Weisblum Yiska, Muecksch Frauke, Hoffmann Hans-Heinrich, Michailidis Eleftherios, Lorenzi Julio C.C., Mendoza Pilar et al (2020) Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20201181","journal-title":"J Exp Med"},{"key":"7020_CR50","doi-asserted-by":"publisher","DOI":"10.3390\/v12050513","author":"KHD Crawford","year":"2020","unstructured":"Crawford KHD, Eguia R, Dingens AS, Loes AN, Malone KD, Wolf CR, Chu HY et al (2020) Protocol and reagents for pseudotyping lentiviral particles with SARS- CoV-2 spike protein for neutralization assays. Viruses. https:\/\/doi.org\/10.3390\/v12050513","journal-title":"Viruses"},{"key":"7020_CR51","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.143213","author":"Cong Zeng","year":"2020","unstructured":"Zeng Cong, Evans John P, Pearson Rebecca, Panke Qu, Zheng Yi-Min, Robinson Richard T, Hall-Stoodley Luanne et al (2020) Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers, and convalescent plasma donors. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.143213","journal-title":"JCI Insight"},{"key":"7020_CR52","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2100362","author":"SS Abdool Karim","year":"2021","unstructured":"Abdool Karim SS, de Oliveira T (2021) New SARS-CoV-2 variants\u2014clinical, public health, and vaccine implications. N Engl J Med. https:\/\/doi.org\/10.1056\/NEJMc2100362","journal-title":"N Engl J Med"},{"issue":"10273","key":"7020_CR53","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/S0140-6736(21)00298-1","volume":"397","author":"T Burki","year":"2021","unstructured":"Burki T (2021) Understanding variants of SARS-CoV-2. The Lancet 397(10273):462. https:\/\/doi.org\/10.1016\/S0140-6736(21)00298-1","journal-title":"The Lancet"},{"key":"7020_CR54","doi-asserted-by":"publisher","unstructured":"Yadav, Pragya D., Gajanan N. Sapkal, Priya Abraham, Raches Ella, Gururaj Deshpande, Deepak Y. Patil, Dimpal A Nyayanit, et al. (2021). Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. bioRxiv, Doi:https:\/\/doi.org\/10.1101\/2021.04.23.441101","DOI":"10.1101\/2021.04.23.441101"},{"key":"7020_CR55","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.4388","author":"VV Edara","year":"2021","unstructured":"Edara VV, Hudson WH, Xie X, Ahmed R, Suthar MS (2021) Neutralizing antibodies against SARS-CoV-2 variants after infection and vaccination. JAMA. https:\/\/doi.org\/10.1001\/jama.2021.4388","journal-title":"JAMA"},{"key":"7020_CR56","doi-asserted-by":"publisher","unstructured":"Edara, V. V., C. Norwood, K. Floyd, L. Lai, M. E. Davis-Gardner, W. H. Hudson, G. Mantus, et al. (2021). Reduced binding and neutralization of infection- and vaccine-induced antibodies to the B.1.351 (South African) SARS-CoV-2 variant. bioRxiv. Doi:https:\/\/doi.org\/10.1101\/2021.02.20.432046.","DOI":"10.1101\/2021.02.20.432046"},{"issue":"4","key":"7020_CR57","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","volume":"27","author":"RE Chen","year":"2021","unstructured":"Chen RE, Zhang X, Case JB, Winkler ES, Liu Y, VanBlargan LA, Liu J et al (2021) Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat Med 27(4):717\u2013726. https:\/\/doi.org\/10.1038\/s41591-021-01294-w","journal-title":"Nat Med"},{"key":"7020_CR58","doi-asserted-by":"publisher","first-page":"e61312","DOI":"10.7554\/eLife.61312","volume":"9","author":"Y Weisblum","year":"2020","unstructured":"Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC et al (2020) Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife 9:e61312. https:\/\/doi.org\/10.7554\/eLife.61312","journal-title":"eLife"},{"key":"7020_CR59","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abi6950","author":"RR Goel","year":"2021","unstructured":"Goel RR, Apostolidis SA, Painter MM, Mathew D, Pattekar A, Kuthuru O et al (2021) Distinct antibody and memory B cell responses in SARS-CoV-2 na\u00efve and recovered individuals following mRNA vaccination. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.abi6950","journal-title":"Sci Immunol"},{"issue":"6522","key":"7020_CR60","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1126\/science.abe1107","volume":"370","author":"KW Ng","year":"2020","unstructured":"Ng KW, Faulkner N, Cornish GH, Rosa A, Harvey R, Hussain S et al (2020) Preexisting and de novo humoral immunity to SARS-CoV-2 in humans. Science 370(6522):1339\u20131343. https:\/\/doi.org\/10.1126\/science.abe1107","journal-title":"Science"},{"issue":"3","key":"7020_CR61","doi-asserted-by":"publisher","first-page":"e214302","DOI":"10.1001\/jamanetworkopen.2021.4302","volume":"4","author":"HS Yang","year":"2021","unstructured":"Yang HS, Costa V, Racine-Brzostek SE, Acker KP, Yee J, Chen Z et al (2021) Association of Age With SARS-CoV-2 Antibody Response. JAMA Netw Open 4(3):e214302\u2013e214302. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.4302","journal-title":"JAMA Netw Open"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-021-07020-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-021-07020-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,22]],"date-time":"2022-02-22T07:27:27Z","timestamp":1645514847000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-021-07020-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":61,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["7020"],"URL":"https:\/\/doi.org\/10.1007\/s11033-021-07020-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]},"assertion":[{"value":"13 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no potential competing interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No animal has been used in this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors are agree to publish this manuscript in your valuable journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}